ResMed, Inc. (RMD)
271.63
+4.58
(+1.72%)
USD |
NYSE |
Feb 06, 16:00
271.75
+0.12
(+0.04%)
Pre-Market: 04:55
ResMed EPS Diluted (Quarterly) : 2.682 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 1.017 |
| Baxter International, Inc. | 0.0175 |
| Stryker Corp. | 2.20 |
| Insulet Corp. | 1.240 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 392.59M |
| Revenue (Quarterly) | 1.423B |
| Total Expenses (Quarterly) | 1.030B |
| Enterprise Value | 38.99B |
| Gross Profit Margin (Quarterly) | 60.93% |
| Profit Margin (Quarterly) | 27.59% |
| Earnings Yield | 3.72% |
| Operating Earnings Yield | 4.63% |
| Normalized Earnings Yield | 3.762 |